Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie - 1 Mar 2001

Barthellemy S, Maurin N, Roussey M, Férec C, Murolo S, Berthézène P, Iovanna J L, Dagorn J C, Sarles J

Abstract excerpt

OBJECTIVES: The increasing evidence of the benefits of neonatal screening for cystic fibrosis (CF) indicates that this procedure could soon be implemented throughout France. The screening strategy currently used involves the detection of infants with elevated levels of immunoreactive trypsinogen (IRT) (approximately 1% of the population), followed by the detection of CFTR gene mutations. However, genetic analysis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute-Phase Proteins
Share to Feasibility Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lectins, C-Type

Share to Neonatal Screening

Share to Pancreatitis-Associated Proteins

Share to Patient Selection

Share to Program Evaluation

Share to Trypsinogen

Source

Identifiers

PMID: 11270251
DOI: 10.1016/s0929-693x(00)00194-9

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].PMID 11270251Read ↗

Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.Semantic proximity Read ↗

Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.Semantic proximity Read ↗

Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic StudiesSemantic proximity Read ↗

[Pancreatitis in cystic fibrosis: association with genotype and pancreatic status].Semantic proximity Read ↗

Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands.Semantic proximity Read ↗

CFTR and cationic trypsinogen mutations in idiopathic pancreatitis and neonatal hypertrypsinemia.Semantic proximity Read ↗

Combining Immunoreactive Trypsinogen and Pancreatitis-Associated Protein Assays, a Method of Newborn Screening for Cystic Fibrosis that Avoids DNA AnalysisSemantic proximity Read ↗

[National program for neonatal screening for cystic fibrosis: implementation and preliminary results].Semantic proximity Read ↗

Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.Semantic proximity Read ↗

Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.Semantic proximity Read ↗

Neonatal screening for cystic fibrosis: France rises to the challenge.Semantic proximity Read ↗

[Frequency of CFTR gene mutations in idiopathic pancreatitis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.